Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Kanae Gamo, Hiroyuki Miyachi, Kayoko Nakamura & Nobuyasu Matsuura. (2014) Hesperetin glucuronides induce adipocyte differentiation via activation and expression of peroxisome proliferator-activated receptor-γ. Bioscience, Biotechnology, and Biochemistry 78:6, pages 1052-1059.
Read now
Read now
Ming
Ji Jin, Unyong Kim, In
Sook Kim, Yuri Kim, Dong-Hyun Kim, Sang
Beom Han, Dong-Hyun Kim, Oh-Seung Kwon & Hye
Hyun Yoo. (2010) Effects of Gut Microflora on Pharmacokinetics of Hesperidin: A Study on Non-Antibiotic and Pseudo-Germ-Free Rats. Journal of Toxicology and Environmental Health, Part A 73:21-22, pages 1441-1450.
Read now
Read now
Eun
Jeong Choi. (2007) Hesperetin Induced G1-Phase Cell Cycle Arrest in Human Breast Cancer MCF-7 Cells: Involvement of CDK4 and p21. Nutrition and Cancer 59:1, pages 115-119.
Read now
Read now
Christine Morand, Claudine Manach, Vanessa Crespy & Christian Remesy. (2000) Quercetin 3-O-β-glucoside is better absorbed than other quercetin forms and is not present in rat plasma. Free Radical Research 33:5, pages 667-676.
Read now
Read now
PeterC. H. Hollman, LilianB. M. Tijburg & ChungS. Yang. (1997) Bioavailability of flavonoids from tea. Critical Reviews in Food Science and Nutrition 37:8, pages 719-738.
Read now
Read now
I. Skjevrak, E. Solheim & R. R. Scheline. (1986) Dihydrochalcone metabolism in the rat: trihydroxylated derivatives related to phloretin. Xenobiotica 16:1, pages 35-45.
Read now
Read now
S. Brown & L. A. Griffiths. (1983) Metabolism and excretion of butein, 2′,3,4-trihydroxychalcone, 3-O-methylbutein, 4-O-methylbutein and 2′,4′,4-trihydroxychalcone in the rat. Xenobiotica 13:11, pages 669-682.
Read now
Read now
Articles from other publishers (27)
Ramadan M. Abdelaziz, Ahmed Z. Abdelazem, Khalid S. Hashem & Yasser A. Attia. (2020) Protective effects of hesperidin against MTX-induced hepatotoxicity in male albino rats. Naunyn-Schmiedeberg's Archives of Pharmacology 393:8, pages 1405-1417.
Crossref
Crossref
Chenlin Shen, Zhengyue Qian, Ruonan Chen, Xiaoming Meng, Tingting Hu, Zhaolin Chen, Yangyang Li, Cheng Huang, Chaojie Hu & Jun Li. (2015) Single Dose Oral and Intravenous Pharmacokinetics and Tissue Distribution of a Novel Hesperetin Derivative MTBH in Rats. European Journal of Drug Metabolism and Pharmacokinetics 41:6, pages 675-688.
Crossref
Crossref
. (2010) Flavouring Group Evaluation 32 (FGE.32): Flavonoids (Flavanones and dihydrochalcones) from chemical groups 25 and 30. EFSA Journal 8:9, pages 1065.
Crossref
Crossref
Constance Bock, Karl-Heinz Waldmann & Waldemar Ternes. (2008) Mangiferin and hesperidin metabolites are absorbed from the gastrointestinal tract of pigs after oral ingestion of a Cyclopia genistoides (honeybush tea) extract. Nutrition Research 28:12, pages 879-891.
Crossref
Crossref
F I Kanaze, M I Bounartzi, M Georgarakis & I Niopas. (2006) Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. European Journal of Clinical Nutrition 61:4, pages 472-477.
Crossref
Crossref
Hikaru Matsumoto, Yoshinori Ikoma, Minoru Sugiura, Masamichi Yano & Yoshinori Hasegawa. (2004) Identification and Quantification of the Conjugated Metabolites Derived from Orally Administered Hesperidin in Rat Plasma. Journal of Agricultural and Food Chemistry 52:21, pages 6653-6659.
Crossref
Crossref
Toshiyuki Kohri, Masayuki Suzuki & Fumio Nanjo. (2003) Identification of Metabolites of (−)-Epicatechin Gallate and Their Metabolic Fate in the Rat. Journal of Agricultural and Food Chemistry 51:18, pages 5561-5566.
Crossref
Crossref
C Manach, C Morand, A Gil-Izquierdo, C Bouteloup-Demange & C Rémésy. (2003) Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. European Journal of Clinical Nutrition 57:2, pages 235-242.
Crossref
Crossref
Hae Kyung Kim, Tae-Sook Jeong, Mi-Kyung Lee, Yong Bok Park & Myung-Sook Choi. (2003) Lipid-lowering efficacy of hesperetin metabolites in high-cholesterol fed rats. Clinica Chimica Acta 327:1-2, pages 129-137.
Crossref
Crossref
Hitoshi Matsumoto, Hiromi Inaba, Mitsuo Kishi, Shigeru Tominaga, Masao Hirayama & Takanori Tsuda. (2001) Orally Administered Delphinidin 3-Rutinoside and Cyanidin 3-Rutinoside Are Directly Absorbed in Rats and Humans and Appear in the Blood as the Intact Forms. Journal of Agricultural and Food Chemistry 49:3, pages 1546-1551.
Crossref
Crossref
Catherine Felgines, Odile Texier, Christine Morand, Claudine Manach, Augustin Scalbert, Françoise Régerat & Christian Rémésy. (2000) Bioavailability of the flavanone naringenin and its glycosides in rats. American Journal of Physiology-Gastrointestinal and Liver Physiology 279:6, pages G1148-G1154.
Crossref
Crossref
Kazuaki Kida, Masayuki Suzuki, Natsuki Matsumoto, Fumio Nanjo & Yukihiko Hara. (2000) Identification of Biliary Metabolites of (−)-Epigallocatechin Gallate in Rats. Journal of Agricultural and Food Chemistry 48:9, pages 4151-4155.
Crossref
Crossref
Ulla Justesen, Eva Arrigoni, Bo R Larsen & Renato Amado. (2000) Degradation of Flavonoid Glycosides and Aglycones During in vitro Fermentation with Human Faecal Flora. LWT - Food Science and Technology 33:6, pages 424-430.
Crossref
Crossref
F.A. Tomás-Barberan, F. Ferreres & M.I. Gil. 2000. Bioactive natural Products (Part D). Bioactive natural Products (Part D)
739
795
.
Ruksana Choudhury, George Chowrimootoo, Kaila Srai, Edward Debnam & Catherine A. Rice-Evans. (1999) Interactions of the Flavonoid Naringenin in the Gastrointestinal Tract and the Influence of Glycosylation. Biochemical and Biophysical Research Communications 265:2, pages 410-415.
Crossref
Crossref
Lisa J. Wilcox, Nica M. Borradaile & Murray W. Huff. (2006) Antiatherogenic Properties of Naringenin, a Citrus Flavonoid. Cardiovascular Drug Reviews 17:2, pages 160-178.
Crossref
Crossref
Jörg Heilmann & Irmgard Merfort. (2006) Aktueller Kenntnisstand zum Metabolismus von Flavonoiden II. Resorption und Metabolismus von Flavonen, Flavanonen, Flavanen, Proanthocyanidinen und Isoflavonoiden. Pharmazie in unserer Zeit 27:4, pages 173-183.
Crossref
Crossref
Irmgard Merfort & Irmgard Merfort. (2006) Aktueller Kenntnisstand zum Metabolismus von Flavonoiden I. Resorption und Metabolismus von Flavonolen. Pharmazie in unserer Zeit 27:2, pages 58-65.
Crossref
Crossref
Y. H. He & C. Kies. (1994) Green and black tea consumption by humans: Impact on polyphenol concentrations in feces, blood and urine. Plant Foods for Human Nutrition 46:3, pages 221-229.
Crossref
Crossref
Weici Tang & Gerhard EisenbrandWeici Tang & Gerhard Eisenbrand. 1992. Chinese Drugs of Plant Origin. Chinese Drugs of Plant Origin
337
349
.
JOSEPH P. BROWN. 1988. Role of the Gut Flora in Toxicity and Cancer. Role of the Gut Flora in Toxicity and Cancer
109
144
.
WOLFGANG BARZ & KLAUS-MICHAEL WELTRING. 1985. Biosynthesis and Biodegradation of Wood Components. Biosynthesis and Biodegradation of Wood Components
607
666
.
Luc P. Balant & Maurice Wermeille. (1984) METABOLISM AND PHARMACOKINETICS OF HYDROXYETHYLATED RUTOSIDES IN ANIMALS AND MAN. Drug Metabolism and Drug Interactions 5:1, pages 1-24.
Crossref
Crossref
S. Brown & L. A. Griffiths. (1983) New metabolites of the naturally-occurring mutagen, quercetin, the pro-mutagen, rutin and of taxifolin. Experientia 39:2, pages 198-200.
Crossref
Crossref
Jelka Tomašić. 1983. Drug Metabolite Isolation and Determination. Drug Metabolite Isolation and Determination
149
160
.
Leslie A. Griffiths. 1982. The Flavonoids. The Flavonoids
681
718
.
Vernon L. Singleton. 1981.
149
242
.